Encompass Health Corporation filings document the operating results, financing arrangements and governance matters of a public inpatient rehabilitation hospital company. Its Form 8-K reports furnish earnings releases, Regulation FD materials, same-store performance measures and non-GAAP metrics such as adjusted earnings per share, leverage ratio, Adjusted EBITDA and adjusted free cash flow.
Other filings record capital-structure and governance subjects, including the company's credit agreement, revolving credit facility, subsidiary guarantor arrangements, board appointments, committee assignments and director compensation practices. The definitive proxy statement addresses annual meeting proposals, executive compensation, pay-versus-performance disclosure, board structure and stockholder voting matters.
Encompass Health Corp executive Patrick William Tuer, EVP and Chief Operating Officer, reported a tax-related share disposition. On the reported date, 506 shares of Encompass Health common stock were withheld or surrendered at $106.15 per share to cover tax withholding obligations from vesting restricted stock. After this tax-withholding disposition, Tuer directly owned 25,982 shares of Encompass Health common stock.
Encompass Health Corp EVP & Chief Financial Officer Douglas E. Coltharp reported a Form 4 transaction involving Encompass Health Common Stock. On February 23, 2026, 14,818 shares were disposed of at $106.15 per share under code F, which indicates a tax-withholding disposition to satisfy tax obligations tied to vesting restricted stock, rather than an open-market sale. After this withholding event, he directly owns 70,153 shares, with additional indirect holdings reported through an irrevocable trust, an irrevocable trust for the benefit of his children, and his spouse.
Encompass Health Corp Chief Accounting Officer Andrew L. Price disposed of 404 shares of Encompass Health common stock on a tax-withholding basis. The shares, valued at $106.15 each, were withheld to cover taxes due upon vesting of related restricted stock. After this transaction, Price held 75,001 shares directly.
Encompass Health Corp’s Chief Medical Officer, Elissa Joy Charbonneau, reported a tax-related share disposition. On this Form 4, 440 shares of Encompass Health common stock were withheld to cover tax obligations from vesting restricted stock, at a reference price of $106.15 per share. After this tax-withholding transaction, she held a total of 18,013.061 shares directly.
Encompass Health Corp executive John Patrick Darby reported a tax-related share disposition. On February 23, 2026, he disposed of 6,990 shares of Encompass Health common stock at a price of $106.15 per share to cover tax withholding obligations tied to vesting restricted stock.
After this tax-withholding transaction, Darby directly owned 84,363 shares of Encompass Health common stock. The filing describes the event as shares withheld or surrendered to pay tax liabilities, rather than an open-market sale.
Encompass Health Corp's chief medical officer, Elissa Joy Charbonneau, reported two share dispositions tied to tax withholding on vested restricted stock. On February 19, 2026, 4,016 Encompass Health common shares were withheld at $107.15 per share. On February 20, 2026, 287 shares were withheld at $106.55 per share. After these non-market, tax-related transactions, she directly owned 18,453.061 Encompass Health shares.
Encompass Health Corp President & CEO Mark J. Tarr reported two tax-related share dispositions of Encompass Health common stock. On February 19, 43,378 shares were withheld at $107.15 per share, and on February 20, 1,797 shares were withheld at $106.55 per share.
According to the disclosure, these shares were withheld or surrendered to cover tax withholding obligations tied to the vesting of restricted stock, rather than open-market sales. After these transactions, Tarr directly owned 445,637 Encompass Health shares.
Encompass Health Corp senior vice president and treasurer Edmund Fay reported two tax-related share dispositions in Encompass Health common stock. On February 19, 3,479 shares were withheld at $107.15 per share, and on February 20, 208 shares were withheld at $106.55 per share to cover tax withholding on vested restricted stock. After these transactions, Fay directly owned 101,922 shares of Encompass Health common stock.
Encompass Health Corp Chief Accounting Officer Andrew L. Price reported two tax-related share dispositions under an equity award. On February 19, 2026, 3,692 shares of Encompass Health common stock were surrendered at $107.15 per share, and on February 20, 2026, a further 228 shares were surrendered at $106.55 per share.
According to the footnote, these shares were withheld or surrendered to pay tax withholding obligations triggered by the vesting of related restricted stock, rather than sold as discretionary open-market trades. After these transactions, Price directly owned 75,405 shares of Encompass Health common stock.
Encompass Health Corp executive John Patrick Darby reported routine tax-related share dispositions. On February 19, 2026 and February 20, 2026, a total of 8,231 shares of Encompass Health common stock were withheld or surrendered to cover tax withholding obligations from vesting restricted stock. These transactions, coded “F,” reflect tax-withholding dispositions rather than open-market sales, and Darby continued to hold 91,353 shares directly after the most recent transaction.